7-107202518-G-GAA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000297135.9(COG5):c.*997_*998insTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 151,922 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Consequence
COG5
ENST00000297135.9 3_prime_UTR
ENST00000297135.9 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.121
Genes affected
COG5 (HGNC:14857): (component of oligomeric golgi complex 5) The protein encoded by this gene is one of eight proteins (Cog1-8) which form a Golgi-localized complex (COG) required for normal Golgi morphology and function. The encoded protein is organized with conserved oligomeric Golgi complex components 6, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants. Mutations in this gene result in congenital disorder of glycosylation type 2I.[provided by RefSeq, Jan 2011]
HBP1 (HGNC:23200): (HMG-box transcription factor 1) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of lipid transport; negative regulation of reactive oxygen species biosynthetic process; and negative regulation of transcription by RNA polymerase II. Located in nuclear speck. Biomarker of osteoarthritis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG5 | NM_006348.5 | c.*997_*998insTT | 3_prime_UTR_variant | 22/22 | ENST00000297135.9 | NP_006339.4 | ||
HBP1 | NM_012257.4 | c.*1087_*1088insAA | 3_prime_UTR_variant | 11/11 | ENST00000222574.9 | NP_036389.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBP1 | ENST00000222574.9 | c.*1087_*1088insAA | 3_prime_UTR_variant | 11/11 | 1 | NM_012257.4 | ENSP00000222574 | P1 | ||
COG5 | ENST00000297135.9 | c.*997_*998insTT | 3_prime_UTR_variant | 22/22 | 1 | NM_006348.5 | ENSP00000297135 | P2 | ||
COG5 | ENST00000347053.8 | c.*997_*998insTT | 3_prime_UTR_variant | 21/21 | 1 | ENSP00000334703 | A2 | |||
HBP1 | ENST00000468410.5 | downstream_gene_variant | 2 | ENSP00000420500 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151922Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151922Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74190
GnomAD4 genome
AF:
AC:
2
AN:
151922
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Congenital disorder of glycosylation Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at